Most Popular Stories
- Hospitals lose reimbursement for 'unnecessary' ER visits
- Healthcare jobs will grow the fastest of all industries
- Online tools, social media ease clinical recruiting, research
- Hospital exec arrested in $116M Medicare scheme
- Docs not always honest with patients
- Medicaid cuts loom despite overdue reimbursements
Featured Jobs
-
ICD-10 Revenue Cycle, Manager
Meditology Services - Atlanta, GA -
Electronic Health Records Application Support Manager RN-New Year New Career
Avanti on behalf of Respected Health System - San Francisco, CA -
Epic Ambulatory Beacon Consultant
Meditology Services - NC
Events
- CIO Healthcare Summit
March 11-14 — Scottsdale, AZ - IHI's Transforming the Primary Care Practice
May 1-3, 2012 — San Diego, CA - Medicare Risk Adjusted Revenue and Plan Payments
April 12 - 13, 2012 — Baltimore, MD - 3rd Healthcare IT Innovation Asia
Mar 14-15 2012 — Singapore
Paid Research Reports
- Electronic health records: getting it right first time
- Cloud Computing Adoption In The APAC Life Sciences Industry
- Stakeholder Opinions: Ophthalmology - Leading brands under threat
- Genomics, Proteomics and Metabolomics in Diagnostics: Market landscape, innovative technologies and future outlook
- Healthcare Regulatory Update: The United Arab Emirates
- Point of Care Testing: Evaluating the return to evidence based medicine, novel technologies and the competitive landscape
Free Newsletter
FierceHealthcare is the leading source of healthcare management news for healthcare industry executives. Join 50,000+ healthcare industry insiders who get FierceHealthcare via daily email. Sign up today!
Popular Topics
Angioplasty procedures in decline
According to an article published in USA Today, angioplasty procedures--performed 650,000 to 1 million times per year in the U.S. alone--are on the decline. Recent studies that have concluded that the procedure is "riskier" than necessary and "no more beneficial than medication" are seen is primary reasons for its drop in number. The cost of the procedure--which is usually between $10,000 and $12,000--and overuse also are seen as a major factors in the decline. Overall, angioplasties have declined by 10 to 15 percent over the last two years, according to the article.Â
For more information:
- read a blog in the Wall Street Journal
- check out USA Today's take
Related Stories
Home
| Subscribe | Advertise | Mobile Edition | RSS |
Privacy
| Site Map
| Editors | List in Marketplace | Supplier in MarketplaceTHE FIERCEMARKETS NETWORKFierceEnergy | FierceSmartGrid | FierceFinance | FierceFinanceIT | FierceComplianceIT | FierceHealthcare | FierceHealthFinance | FierceHealthIT | Hospital Impact | FierceMobileHealthcare | FierceHealthPayer | FiercePracticeManagement | FierceEMR | FierceCIO | FierceCIO:TechWatch | FierceContentManagement | FierceMobileIT | FierceGovernmentIT | FierceGovernment | FierceHomelandSecurity | FierceBiotech | FierceBiotech Research | FiercePharma | FierceVaccines | FierceBiotechIT | FiercePharma Manufacturing | FierceMedicalDevices | FierceDrugDelivery | FierceIPTV | FierceOnlineVideo | FierceTelecom | FierceEnterpriseCommunications | FierceBroadbandWireless | FierceDeveloper | FierceMobileContent | FierceWireless | FierceWireless:Europe | FierceCable© 2011 FierceMarkets. All rights reserved. |
![]() |
